Introduction: Paracetamol (PCM) is one of the commonest drug in clinical practice and it is generally safe for use at recommended doses. However, its overdose can cause mild hepatotoxicity to severe hepatic necrosis and even hepatic failure. N-acetylcysteine (NAC) is the standard recommended antidote for PCM poisoning which is available in both intravenous (IV) and oral formulations. This study aimed to measure outcome in PCM poisoning after treatment with oral or IV NAC.
INTRODUCTION
Paracetamol (PCM, Acetaminophen) is one of the most widely used drug in the world. It is an effective mild analgesic, antipyretic agent which is inexpensive and mostly sold as an over the counter drug. It is generally safe for use at recommended doses (1000 mg per single dose and up to 4000 mg/ day for adults and 2000 mg/day for alcoholics). 1, 2 PCM poisoning occurs mostly because of suicidal tendencies and less commonly accidental. It is a major public health problem in the Western world mainly Europe and United States of America. 3 However this is becoming one of the public health problem in our country as well especially among youngsters in urban areas. 4 PCM has a narrow therapeutic index and the therapeutic dose is close to the toxic dose. To cause toxicity, an acute overdose must total be more than or equal to 150 mg/kg (about 7.5 gram in adults) within 24 hours. 5, 6 Its overdose can cause mild hepatotoxicity to severe hepatic centrilobular necrosis and even liver failure. However, mostly the catastrophic outcomes and liver related deaths are uncommon who present to the hospital within 16 hrs of ingestion. 7 Though mechanism of PCM induced liver injury is still not completely understood, in the initial phases of toxicity PCM is metabolically activated by cytochrome P450 enzymes to a reactive intermediate metabolite, Nacetyl-p-benzoquinoneimine (NAPQI) that depletes glutathione (GSH) and covalently bind to cellular proteins including mitochondrial proteins. 8 The estimated serum PCM concentration in relation to the post ingestion time is interpreted using the nomogram. The standard nomogram recommends estimation of serum PCM level every four hours, which is plotted in a graph. This guides for general line of management whether the case falls within standard treatment line or high risk treatment line and it also provides clinicians a method to predict whether patients would develop hepatic toxicity following an initial serum level after an overdose of PCM. 9 N-acetylcysteine (NAC) is the standard recommended antidote for PCM poisoning that acts by repletion of GSH. It is available in both oral and intravenous (IV) forms. 10 The IV formulation has been available in Europe for over 30 years but Since then debate of superiority of oral and IV NAC started and numerous researches carried out and still going on to the subject. 5, 11 The approved therapeutic duration for oral NAC is 72 hours (140 mg/kg body weight stat followed by 17 doses of 70 mg/kg every 4 hours with a total dose of 1330 mg/kg over 72 hours) and IV NAC is 20 hours (150 mg/kg in 200 ml of 5% Dextrose over 15 minutes followed by 50 mg/kg in 500 ml of 5% Dextrose over next 4 hours and then 100 mg/kg in one liter of 5% Dextrose over next 16 hours with a total dose of 300 mg/kg given over 20 hours). 7, 12 Available formulations of NAC in our market, (Tablet NACFIL 600 mg: Fourt's India Ltd, Tamil Nadu, India; Injection Mucomix 20%: Samarth Life Sciences Pvt Ltd, Himanchal Pradesh, India). M a n y r e s e a r c h e s h a v e s h o w n t h a t b o t h formulations are equally effective and some comparative studies have even shown that oral forms have better outcomes in those who present late for treatment in hospitals. 13, 14 The facilities of toxicological analysis are not and there is no separate study as such till date in our country. 15 Our aim in this study was to measure outcome of 
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RESULTS
Out of 50 cases 20 (40%) were treated with oral NAC and 30 (60%) with IV NAC. PCM poisoning was more common in young adults (15-30 years) with mean age of 19 (n=43; 86%) and most of them had taken with an intent of suicide (n=47; 94%).
Majority of patients were asymptomatic at presentation with female preponderance (M:F=1:4; 80%) and most were unmarried (n=46; 92%) and were students (n=41; 82%).
As an outcome measure there were no severe liver enzymes derangement (Table 1) , no serious adverse drug reactions (Table 2 ), no statistical difference in early and late presenters in both the treatment groups (Table 3 ) with 100% cure rate without any mortality in both oral and IV NAC groups.
DISCUSSION
In our study amount of PCM consumed was al., 25 oral NAC appeared to be more effective than IV.
Our study had some limitations. Firstly, the sample size may be small to make any conclusion.
Secondly, we may be at the tip of the iceberg with bulk of the cases not coming to our notice. Thirdly, However, it is better to individualize the treatment regimen.
